These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3780828

  • 1. Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone.
    Colin JN, Farinotti R, Fredj G, Tod M, Clavel JP, Vignon E, Dietlin F.
    Eur J Clin Pharmacol; 1986; 31(1):53-8. PubMed ID: 3780828
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
    Walter-Sack I, de Vries JX, Kutschker C, Ittensohn A, Voss A.
    Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability].
    Schuster O, Haertel M, Hugemann B, Gikalov I, Schiemann O, Fenner H.
    Arzneimittelforschung; 1985; 35(4):760-5. PubMed ID: 4015743
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacokinetic interaction between the active metabolite of allopurinol and benzbromarone].
    Farinotti R, Fredj G, Clavel JP, Colin JN, Nebout T.
    Presse Med; 1986 Mar 22; 15(12):579. PubMed ID: 2939409
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of purine catabolism by benzbromarone in isolated rat liver cells. Comparison with allopurinol and probenecid.
    Rodilla F, Sanchez-Beltran MJ, Izquierdo R, Gomez-Ruiz MD, Cabo J.
    Biochem Pharmacol; 1988 Oct 01; 37(19):3561-3. PubMed ID: 3178870
    [Abstract] [Full Text] [Related]

  • 15. [A study of serum oxipurinol concentration and renal function in patients administered allopurinol].
    Saji M.
    Nihon Jinzo Gakkai Shi; 1996 Dec 01; 38(12):640-50. PubMed ID: 9014485
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.
    Turnheim K, Krivanek P, Oberbauer R.
    Br J Clin Pharmacol; 1999 Oct 01; 48(4):501-9. PubMed ID: 10583019
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a thiazide-allopurinol drug interaction.
    Hande KR.
    Am J Med Sci; 1986 Oct 01; 292(4):213-6. PubMed ID: 3752167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].
    Löffler W, Gröbner W, Zöllner N.
    Arzneimittelforschung; 1983 Oct 01; 33(12):1687-91. PubMed ID: 6686776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.